Brain biopsy in herpes simplex encephalitis.
Routine brain biopsy is often recommended in all patients suspected of having herpes simplex encephalitis (HSE). This approach is based upon the lack of ability to make the diagnosis of HSE on clinical grounds, the need to exclude other diseases for which there is specific therapy, and to stop empiric therapies. Acyclovir is a relatively safe, effective antiviral agent with little toxicity as currently used to treat HSE. Thus this is not a problem. Careful review of alternate diagnoses established at brain biopsy reveals few for which biopsy is the only and best way of making the diagnosis. Thus empiric therapy with acyclovir should be considered in some children in whom all appropriate diagnostic techniques fail to establish specifically treatable diseases. Early detection of HSV antigen in CSF may provide a non-invasive means of early diagnosis in the future.
Fishman
M A
MA
Department of Pediatrics, Baylor College of Medicine, Texas, Houston 77030.
D000212:Acyclovir / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D000956:Antigens, Viral / Q000134:cerebrospinal fluid; D002648:Child; D002675:Child, Preschool; D004660:Encephalitis / Q000134:cerebrospinal fluid / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D005625:Frontal Lobe / Q000382:microbiology / Q000473:pathology*; D006561:Herpes Simplex / Q000134:cerebrospinal fluid / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D007223:Infant; D018139:Simplexvirus / Q000187:drug effects / Q000276:immunology / Q000302:isolation & purification*; D013702:Temporal Lobe / Q000382:microbiology / Q000473:pathology*
D000956:Antigens, Viral; D000212:Acyclovir